z-logo
Premium
A phase II study of carfilzomib in the treatment of relapsed/refractory mantle cell lymphoma
Author(s) -
Lee Hun J.,
Badillo Maria,
Romaguera Jorge,
Wang Michael
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15107
Subject(s) - carfilzomib , mantle cell lymphoma , medicine , cyclin d1 , oncology , lenalidomide , proteasome inhibitor , lymphoma , multiple myeloma , cancer research , cancer , cell cycle

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here